Studies using genetically modified mice, lacking the gene encoding ceramide synthase 6 (CerS6), that specifically synthesizes palmitoyl-ceramide, have shown that C16:0-Cer plays a particularly important role in hepatic insulin resistance [34]. The gene discussed is CERS6; the disease is Insulin resistance.